On Saturday March 16, scientists from our unit went out to meet passers-by in Place Pey Berland. We offered workshops with microscopes to observe cells and compare healthy and cancerous tissue. We also offered a DNA extraction workshop. Thanks to curious passers-by for stopping by! Thank you...
The 2024 edition of the "Ma thèse en 180 secondes" scientific mediation competition for doctoral students has been launched! The Université de Bordeaux semi-final took place on March 11 at the Agora du Haut-Carré in Talence with 23 candidates. The aim: to select the 16...
On March 20, Dr Christophe Grosset,Director of Research at Inserm and head of theteam 6 MIRCADE at BRICwill be visiting the French Senate at the request of Senator Florence Lassarade, a member of the Social Affairs Commission and Chair of the "Cancer" study group. He...
The list of topics for the AAP UB PhD Scholarships is online! They are published on ADUM : https://adum.fr/UBX/ptUBPS Applications are open until March 11, 2024 at 12:00 pm, on the university's application platform only. : https://aap.u-bordeaux.fr/ No other deposits will be accepted. You can find out more on...
Team 5 of our TRIO2 unit (Translational Research on Oncodermatology and Rare skin diseases) is heavily involved in the new RHU SPRINT project (Synergie Pour Accélérer l'Innovation Thérapeutique dans les lymphomes T cutanés), coordinated by Pr Adèle de Masson of the Université Paris Cité. RHU...
On February 6, we were honored to welcome Dr Olivier Delattre for the first prestige seminar organized by the unit. Dr Olivier Delattre is Director of Research at the Institut Curie, head of Unit U830 "Cancer, Heterogeneity, Instability and Plasticity" (CHIP) and "INSERM Grand Prix...
Muriel Cario, co-manager of the Aquiderm transfer unit and researcher in Team 5 TRIO2, received with Chrystel Faure (Institut de Chimie et Biologie des membranes et Nano-objets, CBMN) the Galénic dermatology research found prize for their project "Development of a topical targeted immunotherapy for skin...
Press release from theSociété Savante Française de Radiothérapie Oncologique (SFRO) Following the vote of the national elective board, Pr Véronique Vendrely, [team 8 BIOGO of our unit] has been elected President of SFRO, for a two-year term, starting January 17, 2024. SFRO, founded in 1990, issues recommendations...
Team 6 MIRCADE of our BRIC unit and the Paris-based biotech company DeepLife have signed a research collaboration contract with the support of Inserm Transfert, a private subsidiary of InsermThe project aims to harness the power of omics data and perform an in-depth analysis of...
Congratulations to Lea Pechtimaldjian, PhD student Team 05 - Translational Research In Oncodermatology and Orphan skin diseases (TRIO2). for her flash poster presentation at the Département Sciences Biologiques et Médicales (SBM) day which took place on December 11, 2023 at the Domaine du Haut-Carré in...
